Literature DB >> 19561321

Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development.

Armelle Le Campion1, Marie-Claude Gagnerault, Cédric Auffray, Chantal Bécourt, Maud Poitrasson-Rivière, Eliette Lallemand, Boris Bienvenu, Bruno Martin, Françoise Lepault, Bruno Lucas.   

Abstract

Lymphopenia is thought to be a major cause of tolerance breakdown. In a lymphopenic environment, self-recognition events induce some T cells to expand strongly (a mechanism known as spontaneous proliferation). In this study, we show that in C57BL/6 mice, the repertoire resulting from lymphopenia-induced spontaneous CD4(+) T-cell proliferation included a proportion of regulatory T cells as large as that observed in a normal mouse, and no autoimmune disorder was observed. By contrast, in nonobese diabetic mice, differences in the ability of conventional and regulatory T cells to expand in response to lymphopenia led to an unbalance between these 2 T-cell compartments at the expense of regulatory T cells, resulting in the onset of autoimmune diseases. Notably, this accounted for the rapid transfer of diabetes with small numbers of BDC2.5 CD4(+) T cells. Thus, lymphopenia does not itself induce autoimmunity, but it should be considered as a cofactor for the development of autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561321     DOI: 10.1182/blood-2008-12-192120

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.

Authors:  Zachariah McIver; Nicole Stephens; Andrew Grim; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

2.  IL-18 is required for self-reactive T cell expansion in NOD mice.

Authors:  Annette M Marleau; Nora E Sarvetnick
Journal:  J Autoimmun       Date:  2011-03-16       Impact factor: 7.094

Review 3.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 4.  Rho-GTPases as key regulators of T lymphocyte biology.

Authors:  Abdelhadi Saoudi; Sahar Kassem; Anne Dejean; Guillaume Gaud
Journal:  Small GTPases       Date:  2014-05-08

5.  Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Authors:  Ayelet Kaminitz; Keren Mizrahi; Shifra Ash; Avi Ben-Nun; Nadir Askenasy
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 6.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

7.  Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Authors:  Pandelakis A Koni; Anna Bolduc; Mayuko Takezaki; Yutetsu Ametani; Lei Huang; Jeffrey R Lee; Stephen L Nutt; Masahito Kamanaka; Richard A Flavell; Andrew L Mellor; Takeshi Tsubata; Michiko Shimoda
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 8.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

9.  Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.

Authors:  Gerda C Leitner; Nina Worel; Harald Vogelsang
Journal:  Transfus Med Hemother       Date:  2012-07-31       Impact factor: 3.747

10.  Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.

Authors:  Dietmar M W Zaiss; Jorg van Loosdregt; Andrea Gorlani; Cornelis P J Bekker; Andrea Gröne; Maria Sibilia; Paul M P van Bergen en Henegouwen; Rob C Roovers; Paul J Coffer; Alice J A M Sijts
Journal:  Immunity       Date:  2013-01-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.